NIH HIV/AIDS Research Priorities and Guidelines for Determining AIDS Funding

The NIH supports a comprehensive portfolio of biomedical, behavioral, and social science research on HIV and its associated coinfections, comorbidities, and other complications. The Office of AIDS Research (OAR), a component of the NIH Office of the Director, is legislatively mandated to coordinate, plan, evaluate, and budget for the NIH AIDS research program. Building on […]

Addressing the Intersection of Intimate Partner Violence, Trauma, and HIV Conference, July 20, 2015

On July 20, 2015 – The City of Los Angeles AIDS Coordinator’s Office hosted a one-day event, “Addressing the Intersection of Intimate Partner Violence, Trauma, and HIV,” at the California Endowment.  The event was attended by over 180 service providers, including domestic violence counselors, housing specialists, HIV testing and prevention providers, healthcare clinicians, policy-makers, and […]

National HIV/AIDS Strategy for the United States: Updated to 2020

In July 2015, the White House released the National HIV/AIDS Strategy for the United States: Updated to 2020. This Update reflects the work accomplished and the new scientific developments since 2010 and charts a course for collective action across the Federal government and all sectors of society to move us close to the Strategy’s vision. […]

L.A. Trans* Health Summit: Creating Comprehensive Services for the Trans* Community

On June 30, 2015, the Los Angeles County Commission on HIV Transgender Caucus hosted a one-day event entitled, “L.A. Trans* Health Summit: Creating Comprehensive Services for the Trans* Community.” The purpose of the event was to bring together consumers, community members, and service providers to explore the health and HIV needs of the transgender community […]

Young South African Women Can Adhere to Daily PrEP Regimen as HIV Prevention, Study Finds

A clinical study funded by the National Institutes of Health has found that young, single black women in South Africa adhered to a daily pill regimen to prevent HIV infection—an HIV prevention strategy known as pre-exposure prophylaxis, or PrEP. This finding is the first strong indication that this population at substantial HIV risk could accept […]

Stephanie Kovalchik, Ph.D. – Scaled Inverse Probability Weighting for Event Non-Reporting in Ecological Momentary Assessment Studies

Slide presentation: Scaled Inverse Probability Weighting for Event Non-Reporting in Ecological Momentary Assessment Studies Ecological momentary assessment (EMA) is an increasingly popular assessment method in the behavioral sciences that aims to capture events, emotions, and cognitions in real time, usually repeatedly throughout the day. Because EMA typically involves more intensive monitoring than traditional assessment methods, […]

Dr. Yvonne Bryson MD – Progress and Strategies for HIV remission and Cure

CURE overview June 2015 Yvonne Bryson MD Distinguished Professor and Chief Global Pediatric Infectious Disease DGSOM at UCLA, Mattel Children’s  

HIV Prevalence Rates, Risk Factors and Health Disparities Among Transgender Persons

  Dr. Cathy Reback of the CHIPTS Combination Prevention Core, presented to the Los Angeles County Commission on HIV as part of the CHIPTS HIV Research and Community Colloquia Series on Thursday, July 9, 2015. Her presentation provided an overview of the HIV prevalence rates among trans male and female individuals in Los Angeles County.  […]

LA Pride

This past weekend, as part of an initiative to educate people about Pre-Exposure Prophylaxis (PrEP) for HIV prevention, Christopher Street West Association (CSW) partnered with a diverse group of HIV/AIDS and LGBT organizations to participate in LA Pride. Palm cards with information about PrEP were distributed to parade attendants and a PrEP pavilion was set […]

HIV Prevention Trials Network (HPTN) Annual Meeting

On Tuesday, June 16, 2015, Drs. Steve Shoptaw and Raphy Landovitz, from the CHIPTS Combination Prevention Core, delivered well-received plenaries at the HIV Prevention Trials Network (HPTN) Annual Meeting in Washington, DC.  Dr. Shoptaw presented early in the order with a brief but comprehensive presentation on the topic of “Non-Injection Substance Use and HIV.” Dr. […]